Go or no go? Agile and Lipocine hope to make it third time lucky
Smaller projects dominate the list, but this doesn’t make them any less important for November’s hopefuls.
Roche tries again with a new pill for flu
A new influenza antiviral from Roche and Shionogi could become an important new medicine for both groups, if payers can be convinced.
